Exchange Traded Concepts, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Exchange Traded Concepts, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.28 - $1.16 $819,302 - $3.39 Million	2,926,080 Added 86.34%	6,314,948 $2.08 Million
Q1 2024 Apr 15, 2024	BUY	$1.06 - $1.67 $3.05 Million - $4.81 Million	2,881,054 Added 567.34%	3,388,868 $3.93 Million
Q4 2023 Jan 05, 2024	BUY	$1.26 - $1.79 $138,508 - $196,769	109,927 Added 27.63%	507,814 $858,000
Q3 2023 Oct 18, 2023	BUY	$1.61 - $2.54 $522,633 - $824,527	324,617 Added 443.04%	397,887 $720,000
Q2 2023 Jul 20, 2023	BUY	$1.14 - $1.95 $83,527 - $142,876	73,270 New	73,270 $136,000
Q1 2022 Apr 26, 2022	SELL	$2.83 - $8.69 $183,140 - $562,364	-64,714 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$8.31 - $14.92 $537,773 - $965,532	64,714 New	64,714 $538,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.